ibn hayyan pharmaceuticals • 75 mg
Diclon
Product Insights
Diclon is a 75 mg pharmaceutical tablet produced by Ibn Hayyan Pharmaceuticals, marketed primarily in Syria. The medication is intended for therapeutic use as prescribed by a qualified healthcare professional, offering a convenient dosage form for patients. However, detailed ingredient composition and packaging information are not disclosed, limiting consumer insight into potential allergens, side effects, and environmental impact.
Comparative Analysis
Within the Syrian drug market, Diclon’s compact 75 mg tablet format positions it as a convenient, prescription medication, yet the lack of publicly available formulation and packaging details sets it apart from more transparently labeled competitors.
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about Diclon.
